Treatment of chronic hepatitis C in patients with end-stage renal disease and hemophilia - The Singapore experience

Intervirology

Volumn 49, Issue 1-2, 2006, Pages 107-111

  Chow, Wan Cheng ^a   Tien, Sim Leng ^a   Tan, Chee Kiat ^a   Lui, Hock Foong ^a   Vathsala, Anantharaman ^a   Ng, Han Seong ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Hemophilia; Hepatitis C virus; Interferon; Renal failure; Thyroid dysfunction

Indexed keywords

ALPHA2A INTERFERON; ERYTHROPOIETIN; LEVOTHYROXINE; VIRUS RNA;

ADULT; BLEEDING; BLOOD CELL COUNT; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPENIA; DRUG DOSE REDUCTION; DRUG RESPONSE; DRUG TOLERABILITY; FATIGUE; FEMALE; FEVER; FLU LIKE SYNDROME; GENOTYPE; HEMOGLOBIN DETERMINATION; HEMOPHILIA; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPOTHYROIDISM; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MYALGIA; NEUTROPENIA; PRIORITY JOURNAL; RELAPSE; SINGAPORE; THYROID DISEASE;

ADULT; ANTIVIRAL AGENTS; BLOOD CELL COUNT; FEMALE; HEMOPHILIA A; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2A; KIDNEY FAILURE, CHRONIC; LEUKOPENIA; MALE; SINGAPORE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

HEPATITIS C VIRUS;

EID: 24944510414     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087272     Document Type: Conference Paper

References (23)

1. Wang JE: A study on the epidemiology of hepatitis C infection among blood donors in Singapore. J Public Health Med 1995;17:387-391.
2. Choong HL: Hepatitis C in end-stage renal failure (abstract); in Oon CJ, Aw SE and Goh KT (eds): Selected Papers from the International Symposia on Viral Hepatitis and Hepatocellular Carcinoma Research. Singapore, Department of Clinical Research (Ministry of Health), 1992, p 105.
3. Tien SL, Ho LP, Lee ASG, Teng SW, Oon CJ: Hepatitis C infection in haemophilia patients at Singapore General Hospital (abstract). APASL Commemorative International Congress on Viral Hepatitis, Prevention and Control, Singapore, 2000, p 241.
4. Lee AS, Ng KY, Chee MK, Vathsala A, Choong HL, Ng HS, Oon CJ: Partial sequence analysis of the hepatitis C viral genome in Singapore patients. Biochem Biophys Res Commun 1994;199:37-40.
5. Pereira BJ, Levey AS: Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 1997;51:981-999.
6. Huang CC, Liaw YF, Lai MK, Chu SH, Chuang CK, Huang JY: The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992;53:763-765.
7. Chan TM, Wu PC, Lok AS, Lai CL, Cheng IK: Clinicopathological features of hepatitis C virus antibody negative fatal chronic hepatitis C after renal transplantation. Nephron 1995;71:213-217.
8. Nakayama E, Akiba T, Marumo F, Sato C: Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000;11:1896-1902.
9. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ: Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998;32:629-634.
10. Rostaing L, Modesto A. Baron E, Cisterne JM, Chabannier MH, Durand D: Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Nephron 1996;74:512-516.
11. Kakimoto K, Takahara S, Kokado Y, Kameoka H, Ishibashi M, Okuyama A, Kyo M, Nagano S: A case of allograft rejection induced by the interferon-alpha therapy to hepatitis type C after renal transplantation. Hinyokika Kiyo 1994;40:529-532.
12. Duarte R, Huraib S, Said R, Abdel-Khadir A, Sullivan S, Chaballout A, Sbeih F, Mughal T: Interferon-alpha facilitates renal transplantation in hemodialysis patients with chronic viral hepatitis. Am J Kidney Dis 1995;25:40-45.
13. Koenig P, Vogel W, Umlauft F, Weyrer K, Prommegger R, Lhotta K, Neyer U, Stummvoll HK, Gruenewald K: Interferon treatment for chronic hepatitis C virus infection in uremic patients. Kidney Int 1994;45:1507-1509.
14. Fabrizi F, Dulai G, Dixit V, Bunnapradist S, Martin P: Meta-analysis: Interferon for the treatment of chronic hepatitis C in dialysis patients. Aliment Pharmacol Ther 2003;18: 1071-1081.
15. Russo MW, Goldsweig CD, Jacobson IM, Brown RS Jr: Interferon monotherapy for dialysis patients with chronic hepatitis C: An analysis of the literature on efficacy and safety. Am J Gastroenterol 2003;98:1610-1615.
16. Makris M, Preston FE, Triger DR, Underwood JC, Westlake L, Adelman MI: A randomized controlled trial of recombinant interferon-alpha in chronic hepatitis C in hemophiliacs. Blood 1991;78:1672-1677.
17. Rumi MG, Santagostino E, Morfini M, Gringeri A, Tagariello G, Chistolini A, Pontisso P, Tagger A, Colombo M, Mannucci PM: A multicenter controlled, randomized, open trial of interferon alpha2b treatment of anti-human immunodeficiency virus-negative hemophilic patients with chronic hepatitis C. Hepatitis Study Group of the Association of Italian Hemophilia Centers. Blood 1997;89:3529-3533.
18. Dasani H, Loran CM, Collines PW: Treatment of chronic HCV with alpha-interferon and ribavirin in 28 patients with inherited bleeding disorders (abstract). Haemophilia 2000;6: 326.
19. Bruchfeld A, Stahle L, Andersson J, Schvarcz R: Interferon and ribavirin therapy in dialysis patients with chronic hepatitis C. Nephrol Dial Transplant 2001;16:1729-1730.
20. Tan AC, Brouwer JT, Glue P, van Leusen R, Kauffmann RH, Schalm SW, de Vries RA, Vroom B: Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: Results of a pilot study. Nephrol Dial Transplant 2001;16:193-195.
21. Barril G, Quiroga JA, Sanz P, Rodriguez-Salvanes F, Selgas R, Carreno V: Pegylated interferon-alpha2a kinetics during experimental haemodialysis: Impact of permeability and pore size of dialysers. Aliment Pharmacol Ther 2004;20:37-44.
22. Lamb MW, Marks IM, Wynohradnyk L, Modi MW, Preston RA, Pappas SC: 40 KDa peginterferon alfa-2a (Pegasys) can be administered safely in patients with end-sage renal disease (abstract). Hepatology 2001;34:326A.
23. Annicchiarico BE, Siciliano M: Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C. Aliment Pharmacol Ther 2004;20:123-124.